efavirenz has been researched along with Lassitude in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jianwei, L; Menghua, W; Qinwei, Y; Xin, Z; Yu, Z | 1 |
Ding, Y; Gao, M; He, N; Li, L; Lin, H; Liu, X; Shen, W; Wang, K; Wu, Q; Zhou, S | 1 |
2 other study(ies) available for efavirenz and Lassitude
Article | Year |
---|---|
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine | 2020 |
Low body mass index and efavirenz use are independently associated with self-reported fatigue in HIV-infected patients.
Topics: Adult; Age Factors; Alkynes; Anti-Retroviral Agents; Benzoxazines; Body Mass Index; CD4 Lymphocyte Count; China; Cyclopropanes; Fatigue; Female; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Self Report; Time Factors | 2019 |